Title: Full Text of SB1327
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of SB1327 ILGA.GOV SB1327 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB1327 Introduced 1/28/2025, by Sen. Julie A. Morrison SYNOPSIS AS INTRODUCED: 215 ILCS 5/370c.1    Amends the Illinois Insurance Code. Provides that every insurer that amends, delivers, issues, or renews a group or individual policy or certificate of disability insurance or disability income insurance shall ensure parity for the payment of mental, emotional, nervous, or substance use disorders or conditions. Changes the definition of "treatment limitation" to include benefit payments under disability insurance or disability income insurance.LRB104 10928 BAB 21010 b  A BILL FOR SB1327LRB104 10928 BAB 21010 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Insurance Code is amended by 5changing Section 370c.1 as follows: 6    (215 ILCS 5/370c.1)7    Sec. 370c.1. Mental, emotional, nervous, or substance use 8disorder or condition parity.9    (a) On and after July 23, 2021 (the effective date of 10Public Act 102-135), every insurer that amends, delivers, 11issues, or renews a group or individual policy of accident and 12health insurance or a qualified health plan offered through 13the Health Insurance Marketplace in this State providing 14coverage for hospital or medical treatment and for the 15treatment of mental, emotional, nervous, or substance use 16disorders or conditions shall ensure prior to policy issuance 17that:18        (1) the financial requirements applicable to such 19    mental, emotional, nervous, or substance use disorder or 20    condition benefits are no more restrictive than the 21    predominant financial requirements applied to 22    substantially all hospital and medical benefits covered by 23    the policy and that there are no separate cost-sharing   SB1327- 2 -LRB104 10928 BAB 21010 b1    requirements that are applicable only with respect to 2    mental, emotional, nervous, or substance use disorder or 3    condition benefits; and4        (2) the treatment limitations applicable to such 5    mental, emotional, nervous, or substance use disorder or 6    condition benefits are no more restrictive than the 7    predominant treatment limitations applied to substantially 8    all hospital and medical benefits covered by the policy 9    and that there are no separate treatment limitations that 10    are applicable only with respect to mental, emotional, 11    nervous, or substance use disorder or condition benefits.12    (a-5) On and after the effective date of this amendatory 13Act of the 104th General Assembly, every insurer that amends, 14delivers, issues, or renews a group or individual policy or 15certificate of disability insurance or disability income 16insurance in or to any person in this State shall ensure that: 17        (1) the benefits applicable to such mental, emotional, 18    nervous, or substance use disorders or conditions are no 19    more restrictive than the benefits available for all other 20    medical conditions covered by the policy or certificate 21    and that there are no separate requirements that are 22    applicable only with respect to mental, emotional, 23    nervous, or substance use disorder or condition benefits; 24    and 25        (2) the treatment limitations or other coverage 26    limitations applicable to such mental, emotional, nervous,   SB1327- 3 -LRB104 10928 BAB 21010 b1    or substance use disorder or condition benefits are no 2    more restrictive than the benefits available for other 3    physical conditions covered by the policy and that there 4    are no separate payment limitations that may be applied 5    specifically with respect to mental, emotional, nervous, 6    or substance use disorder or condition benefits. 7    (b) The following provisions shall apply concerning 8aggregate lifetime limits:9        (1) In the case of a group or individual policy of 10    accident and health insurance or a qualified health plan 11    offered through the Health Insurance Marketplace amended, 12    delivered, issued, or renewed in this State on or after 13    September 9, 2015 (the effective date of Public Act 14    99-480) that provides coverage for hospital or medical 15    treatment and for the treatment of mental, emotional, 16    nervous, or substance use disorders or conditions the 17    following provisions shall apply:18            (A) if the policy does not include an aggregate 19        lifetime limit on substantially all hospital and 20        medical benefits, then the policy may not impose any 21        aggregate lifetime limit on mental, emotional, 22        nervous, or substance use disorder or condition 23        benefits; or24            (B) if the policy includes an aggregate lifetime 25        limit on substantially all hospital and medical 26        benefits (in this subsection referred to as the   SB1327- 4 -LRB104 10928 BAB 21010 b1        "applicable lifetime limit"), then the policy shall 2        either:3                (i) apply the applicable lifetime limit both 4            to the hospital and medical benefits to which it 5            otherwise would apply and to mental, emotional, 6            nervous, or substance use disorder or condition 7            benefits and not distinguish in the application of 8            the limit between the hospital and medical 9            benefits and mental, emotional, nervous, or 10            substance use disorder or condition benefits; or11                (ii) not include any aggregate lifetime limit 12            on mental, emotional, nervous, or substance use 13            disorder or condition benefits that is less than 14            the applicable lifetime limit.15        (2) In the case of a policy that is not described in 16    paragraph (1) of subsection (b) of this Section and that 17    includes no or different aggregate lifetime limits on 18    different categories of hospital and medical benefits, the 19    Director shall establish rules under which subparagraph 20    (B) of paragraph (1) of subsection (b) of this Section is 21    applied to such policy with respect to mental, emotional, 22    nervous, or substance use disorder or condition benefits 23    by substituting for the applicable lifetime limit an 24    average aggregate lifetime limit that is computed taking 25    into account the weighted average of the aggregate 26    lifetime limits applicable to such categories.   SB1327- 5 -LRB104 10928 BAB 21010 b1    (c) The following provisions shall apply concerning annual 2limits:3        (1) In the case of a group or individual policy of 4    accident and health insurance or a qualified health plan 5    offered through the Health Insurance Marketplace amended, 6    delivered, issued, or renewed in this State on or after 7    September 9, 2015 (the effective date of Public Act 8    99-480) that provides coverage for hospital or medical 9    treatment and for the treatment of mental, emotional, 10    nervous, or substance use disorders or conditions the 11    following provisions shall apply: 12            (A) if the policy does not include an annual limit 13        on substantially all hospital and medical benefits, 14        then the policy may not impose any annual limits on 15        mental, emotional, nervous, or substance use disorder 16        or condition benefits; or17            (B) if the policy includes an annual limit on 18        substantially all hospital and medical benefits (in 19        this subsection referred to as the "applicable annual 20        limit"), then the policy shall either: 21                (i) apply the applicable annual limit both to 22            the hospital and medical benefits to which it 23            otherwise would apply and to mental, emotional, 24            nervous, or substance use disorder or condition 25            benefits and not distinguish in the application of 26            the limit between the hospital and medical   SB1327- 6 -LRB104 10928 BAB 21010 b1            benefits and mental, emotional, nervous, or 2            substance use disorder or condition benefits; or3                (ii) not include any annual limit on mental, 4            emotional, nervous, or substance use disorder or 5            condition benefits that is less than the 6            applicable annual limit. 7        (2) In the case of a policy that is not described in 8    paragraph (1) of subsection (c) of this Section and that 9    includes no or different annual limits on different 10    categories of hospital and medical benefits, the Director 11    shall establish rules under which subparagraph (B) of 12    paragraph (1) of subsection (c) of this Section is applied 13    to such policy with respect to mental, emotional, nervous, 14    or substance use disorder or condition benefits by 15    substituting for the applicable annual limit an average 16    annual limit that is computed taking into account the 17    weighted average of the annual limits applicable to such 18    categories. 19    (d) With respect to mental, emotional, nervous, or 20substance use disorders or conditions, an insurer shall use 21policies and procedures for the election and placement of 22mental, emotional, nervous, or substance use disorder or 23condition treatment drugs on their formulary that are no less 24favorable to the insured as those policies and procedures the 25insurer uses for the selection and placement of drugs for 26medical or surgical conditions and shall follow the expedited   SB1327- 7 -LRB104 10928 BAB 21010 b1coverage determination requirements for substance abuse 2treatment drugs set forth in Section 45.2 of the Managed Care 3Reform and Patient Rights Act. 4    (e) This Section shall be interpreted in a manner 5consistent with all applicable federal parity regulations 6including, but not limited to, the Paul Wellstone and Pete 7Domenici Mental Health Parity and Addiction Equity Act of 82008, final regulations issued under the Paul Wellstone and 9Pete Domenici Mental Health Parity and Addiction Equity Act of 102008 and final regulations applying the Paul Wellstone and 11Pete Domenici Mental Health Parity and Addiction Equity Act of 122008 to Medicaid managed care organizations, the Children's 13Health Insurance Program, and alternative benefit plans.14    (f) The provisions of subsections (b) and (c) of this 15Section shall not be interpreted to allow the use of lifetime 16or annual limits otherwise prohibited by State or federal law.17    (g) As used in this Section:18    "Financial requirement" includes deductibles, copayments, 19coinsurance, and out-of-pocket maximums, but does not include 20an aggregate lifetime limit or an annual limit subject to 21subsections (b) and (c).22    "Mental, emotional, nervous, or substance use disorder or 23condition" means a condition or disorder that involves a 24mental health condition or substance use disorder that falls 25under any of the diagnostic categories listed in the mental 26and behavioral disorders chapter of the current edition of the   SB1327- 8 -LRB104 10928 BAB 21010 b1International Classification of Disease or that is listed in 2the most recent version of the Diagnostic and Statistical 3Manual of Mental Disorders. 4    "Treatment limitation" includes limits on benefits based 5on the frequency of treatment, number of visits, days of 6coverage, days in a waiting period, or other similar limits on 7the scope or duration of treatment, and shall also include 8benefit payments under disability insurance or disability 9income insurance policies or certificates. "Treatment 10limitation" includes both quantitative treatment limitations, 11which are expressed numerically (such as 50 outpatient visits 12per year), and nonquantitative treatment limitations, which 13otherwise limit the scope or duration of treatment, or the 14duration of benefit payments under the terms of a disability 15insurance policy or certificate or disability income insurance 16policy or certificate. A permanent exclusion of all benefits 17for a particular condition or disorder shall not be considered 18a treatment limitation. "Nonquantitative treatment" means 19those limitations as described under federal regulations (26 20CFR 54.9812-1). "Nonquantitative treatment limitations" 21include, but are not limited to, those limitations described 22under federal regulations 26 CFR 54.9812-1, 29 CFR 2590.712, 23and 45 CFR 146.136. 24    (h) The Department of Insurance shall implement the 25following education initiatives:26        (1) By January 1, 2016, the Department shall develop a   SB1327- 9 -LRB104 10928 BAB 21010 b1    plan for a Consumer Education Campaign on parity. The 2    Consumer Education Campaign shall focus its efforts 3    throughout the State and include trainings in the 4    northern, southern, and central regions of the State, as 5    defined by the Department, as well as each of the 5 managed 6    care regions of the State as identified by the Department 7    of Healthcare and Family Services. Under this Consumer 8    Education Campaign, the Department shall: (1) by January 9    1, 2017, provide at least one live training in each region 10    on parity for consumers and providers and one webinar 11    training to be posted on the Department website and (2) 12    establish a consumer hotline to assist consumers in 13    navigating the parity process by March 1, 2017. By January 14    1, 2018 the Department shall issue a report to the General 15    Assembly on the success of the Consumer Education 16    Campaign, which shall indicate whether additional training 17    is necessary or would be recommended.18        (2) The Department, in coordination with the 19    Department of Human Services and the Department of 20    Healthcare and Family Services, shall convene a working 21    group of health care insurance carriers, mental health 22    advocacy groups, substance abuse patient advocacy groups, 23    and mental health physician groups for the purpose of 24    discussing issues related to the treatment and coverage of 25    mental, emotional, nervous, or substance use disorders or 26    conditions and compliance with parity obligations under   SB1327- 10 -LRB104 10928 BAB 21010 b1    State and federal law. Compliance shall be measured, 2    tracked, and shared during the meetings of the working 3    group. The working group shall meet once before January 1, 4    2016 and shall meet semiannually thereafter. The 5    Department shall issue an annual report to the General 6    Assembly that includes a list of the health care insurance 7    carriers, mental health advocacy groups, substance abuse 8    patient advocacy groups, and mental health physician 9    groups that participated in the working group meetings, 10    details on the issues and topics covered, and any 11    legislative recommendations developed by the working 12    group.13        (3) Not later than January 1 of each year, the 14    Department, in conjunction with the Department of 15    Healthcare and Family Services, shall issue a joint report 16    to the General Assembly and provide an educational 17    presentation to the General Assembly. The report and 18    presentation shall: 19            (A) Cover the methodology the Departments use to 20        check for compliance with the federal Paul Wellstone 21        and Pete Domenici Mental Health Parity and Addiction 22        Equity Act of 2008, 42 U.S.C. 18031(j), and any 23        federal regulations or guidance relating to the 24        compliance and oversight of the federal Paul Wellstone 25        and Pete Domenici Mental Health Parity and Addiction 26        Equity Act of 2008 and 42 U.S.C. 18031(j).  SB1327- 11 -LRB104 10928 BAB 21010 b1            (B) Cover the methodology the Departments use to 2        check for compliance with this Section and Sections 3        356z.23 and 370c of this Code.4            (C) Identify market conduct examinations or, in 5        the case of the Department of Healthcare and Family 6        Services, audits conducted or completed during the 7        preceding 12-month period regarding compliance with 8        parity in mental, emotional, nervous, and substance 9        use disorder or condition benefits under State and 10        federal laws and summarize the results of such market 11        conduct examinations and audits. This shall include: 12                (i) the number of market conduct examinations 13            and audits initiated and completed;14                (ii) the benefit classifications examined by 15            each market conduct examination and audit;16                (iii) the subject matter of each market 17            conduct examination and audit, including 18            quantitative and nonquantitative treatment 19            limitations; and20                (iv) a summary of the basis for the final 21            decision rendered in each market conduct 22            examination and audit.23            Individually identifiable information shall be 24        excluded from the reports consistent with federal 25        privacy protections.26            (D) Detail any educational or corrective actions   SB1327- 12 -LRB104 10928 BAB 21010 b1        the Departments have taken to ensure compliance with 2        the federal Paul Wellstone and Pete Domenici Mental 3        Health Parity and Addiction Equity Act of 2008, 42 4        U.S.C. 18031(j), this Section, and Sections 356z.23 5        and 370c of this Code.6            (E) The report must be written in non-technical, 7        readily understandable language and shall be made 8        available to the public by, among such other means as 9        the Departments find appropriate, posting the report 10        on the Departments' websites. 11    (i) The Parity Advancement Fund is created as a special 12fund in the State treasury. Moneys from fines and penalties 13collected from insurers for violations of this Section shall 14be deposited into the Fund. Moneys deposited into the Fund for 15appropriation by the General Assembly to the Department shall 16be used for the purpose of providing financial support of the 17Consumer Education Campaign, parity compliance advocacy, and 18other initiatives that support parity implementation and 19enforcement on behalf of consumers. 20    (j) (Blank). 21    (j-5) The Department of Insurance shall collect the 22following information:23        (1) The number of employment disability insurance 24    plans offered in this State, including, but not limited 25    to:26            (A) individual short-term policies;  SB1327- 13 -LRB104 10928 BAB 21010 b1            (B) individual long-term policies;2            (C) group short-term policies; and3            (D) group long-term policies.4        (2) The number of policies referenced in paragraph (1) 5    of this subsection that limit mental health and substance 6    use disorder benefits.7        (3) The average defined benefit period for the 8    policies referenced in paragraph (1) of this subsection, 9    both for those policies that limit and those policies that 10    have no limitation on mental health and substance use 11    disorder benefits.12        (4) Whether the policies referenced in paragraph (1) 13    of this subsection are purchased on a voluntary or 14    non-voluntary basis.15        (5) The identities of the individuals, entities, or a 16    combination of the 2 that assume the cost associated with 17    covering the policies referenced in paragraph (1) of this 18    subsection.19        (6) The average defined benefit period for plans that 20    cover physical disability and mental health and substance 21    abuse without limitation, including, but not limited to:22            (A) individual short-term policies;23            (B) individual long-term policies;24            (C) group short-term policies; and25            (D) group long-term policies.26        (7) The average premiums for disability income   SB1327- 14 -LRB104 10928 BAB 21010 b1    insurance issued in this State for:2            (A) individual short-term policies that limit 3        mental health and substance use disorder benefits;4            (B) individual long-term policies that limit 5        mental health and substance use disorder benefits;6            (C) group short-term policies that limit mental 7        health and substance use disorder benefits;8            (D) group long-term policies that limit mental 9        health and substance use disorder benefits;10            (E) individual short-term policies that include 11        mental health and substance use disorder benefits 12        without limitation;13            (F) individual long-term policies that include 14        mental health and substance use disorder benefits 15        without limitation;16            (G) group short-term policies that include mental 17        health and substance use disorder benefits without 18        limitation; and19            (H) group long-term policies that include mental 20        health and substance use disorder benefits without 21        limitation.22    The Department shall present its findings regarding 23information collected under this subsection (j-5) to the 24General Assembly no later than April 30, 2024. Information 25regarding a specific insurance provider's contributions to the 26Department's report shall be exempt from disclosure under   SB1327- 15 -LRB104 10928 BAB 21010 b1paragraph (t) of subsection (1) of Section 7 of the Freedom of 2Information Act. The aggregated information gathered by the 3Department shall not be exempt from disclosure under paragraph 4(t) of subsection (1) of Section 7 of the Freedom of 5Information Act.6    (k) An insurer that amends, delivers, issues, or renews a 7group or individual policy of accident and health insurance or 8a qualified health plan offered through the health insurance 9marketplace in this State providing coverage for hospital or 10medical treatment and for the treatment of mental, emotional, 11nervous, or substance use disorders or conditions shall submit 12an annual report, the format and definitions for which will be 13determined by the Department and the Department of Healthcare 14and Family Services and posted on their respective websites, 15starting on September 1, 2023 and annually thereafter, that 16contains the following information separately for inpatient 17in-network benefits, inpatient out-of-network benefits, 18outpatient in-network benefits, outpatient out-of-network 19benefits, emergency care benefits, and prescription drug 20benefits in the case of accident and health insurance or 21qualified health plans, or inpatient, outpatient, emergency 22care, and prescription drug benefits in the case of medical 23assistance: 24        (1) A summary of the plan's pharmacy management 25    processes for mental, emotional, nervous, or substance use 26    disorder or condition benefits compared to those for other   SB1327- 16 -LRB104 10928 BAB 21010 b1    medical benefits.2        (2) A summary of the internal processes of review for 3    experimental benefits and unproven technology for mental, 4    emotional, nervous, or substance use disorder or condition 5    benefits and those for other medical benefits.6        (3) A summary of how the plan's policies and 7    procedures for utilization management for mental, 8    emotional, nervous, or substance use disorder or condition 9    benefits compare to those for other medical benefits.10        (4) A description of the process used to develop or 11    select the medical necessity criteria for mental, 12    emotional, nervous, or substance use disorder or condition 13    benefits and the process used to develop or select the 14    medical necessity criteria for medical and surgical 15    benefits. 16        (5) Identification of all nonquantitative treatment 17    limitations that are applied to both mental, emotional, 18    nervous, or substance use disorder or condition benefits 19    and medical and surgical benefits within each 20    classification of benefits.21        (6) The results of an analysis that demonstrates that 22    for the medical necessity criteria described in 23    subparagraph (A) and for each nonquantitative treatment 24    limitation identified in subparagraph (B), as written and 25    in operation, the processes, strategies, evidentiary 26    standards, or other factors used in applying the medical   SB1327- 17 -LRB104 10928 BAB 21010 b1    necessity criteria and each nonquantitative treatment 2    limitation to mental, emotional, nervous, or substance use 3    disorder or condition benefits within each classification 4    of benefits are comparable to, and are applied no more 5    stringently than, the processes, strategies, evidentiary 6    standards, or other factors used in applying the medical 7    necessity criteria and each nonquantitative treatment 8    limitation to medical and surgical benefits within the 9    corresponding classification of benefits; at a minimum, 10    the results of the analysis shall:11            (A) identify the factors used to determine that a 12        nonquantitative treatment limitation applies to a 13        benefit, including factors that were considered but 14        rejected;15            (B) identify and define the specific evidentiary 16        standards used to define the factors and any other 17        evidence relied upon in designing each nonquantitative 18        treatment limitation;19            (C) provide the comparative analyses, including 20        the results of the analyses, performed to determine 21        that the processes and strategies used to design each 22        nonquantitative treatment limitation, as written, for 23        mental, emotional, nervous, or substance use disorder 24        or condition benefits are comparable to, and are 25        applied no more stringently than, the processes and 26        strategies used to design each nonquantitative   SB1327- 18 -LRB104 10928 BAB 21010 b1        treatment limitation, as written, for medical and 2        surgical benefits;3            (D) provide the comparative analyses, including 4        the results of the analyses, performed to determine 5        that the processes and strategies used to apply each 6        nonquantitative treatment limitation, in operation, 7        for mental, emotional, nervous, or substance use 8        disorder or condition benefits are comparable to, and 9        applied no more stringently than, the processes or 10        strategies used to apply each nonquantitative 11        treatment limitation, in operation, for medical and 12        surgical benefits; and13            (E) disclose the specific findings and conclusions 14        reached by the insurer that the results of the 15        analyses described in subparagraphs (C) and (D) 16        indicate that the insurer is in compliance with this 17        Section and the Mental Health Parity and Addiction 18        Equity Act of 2008 and its implementing regulations, 19        which includes 42 CFR Parts 438, 440, and 457 and 45 20        CFR 146.136 and any other related federal regulations 21        found in the Code of Federal Regulations.22        (7) Any other information necessary to clarify data 23    provided in accordance with this Section requested by the 24    Director, including information that may be proprietary or 25    have commercial value, under the requirements of Section 26    30 of the Viatical Settlements Act of 2009.  SB1327- 19 -LRB104 10928 BAB 21010 b1    (l) An insurer that amends, delivers, issues, or renews a 2group or individual policy of accident and health insurance or 3a qualified health plan offered through the health insurance 4marketplace in this State providing coverage for hospital or 5medical treatment and for the treatment of mental, emotional, 6nervous, or substance use disorders or conditions on or after 7January 1, 2019 (the effective date of Public Act 100-1024) 8shall, in advance of the plan year, make available to the 9Department or, with respect to medical assistance, the 10Department of Healthcare and Family Services and to all plan 11participants and beneficiaries the information required in 12subparagraphs (C) through (E) of paragraph (6) of subsection 13(k). For plan participants and medical assistance 14beneficiaries, the information required in subparagraphs (C) 15through (E) of paragraph (6) of subsection (k) shall be made 16available on a publicly available website whose web address is 17prominently displayed in plan and managed care organization 18informational and marketing materials.19    (m) In conjunction with its compliance examination program 20conducted in accordance with the Illinois State Auditing Act, 21the Auditor General shall undertake a review of compliance by 22the Department and the Department of Healthcare and Family 23Services with Section 370c and this Section. Any findings 24resulting from the review conducted under this Section shall 25be included in the applicable State agency's compliance 26examination report. Each compliance examination report shall   SB1327- 20 -LRB104 10928 BAB 21010 b1be issued in accordance with Section 3-14 of the Illinois 2State Auditing Act. A copy of each report shall also be 3delivered to the head of the applicable State agency and 4posted on the Auditor General's website. 5(Source: P.A. 102-135, eff. 7-23-21; 102-579, eff. 8-25-21; 6102-813, eff. 5-13-22; 103-94, eff. 1-1-24; 103-105, eff. 76-27-23; 103-605, eff. 7-1-24.)


================================================================================

Raw Text:
Full Text of SB1327 ILGA.GOV SB1327 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026SB1327 Introduced 1/28/2025, by Sen. Julie A. Morrison SYNOPSIS AS INTRODUCED: 215 ILCS 5/370c.1    Amends the Illinois Insurance Code. Provides that every insurer that amends, delivers, issues, or renews a group or individual policy or certificate of disability insurance or disability income insurance shall ensure parity for the payment of mental, emotional, nervous, or substance use disorders or conditions. Changes the definition of "treatment limitation" to include benefit payments under disability insurance or disability income insurance.LRB104 10928 BAB 21010 b  A BILL FOR SB1327LRB104 10928 BAB 21010 b1    AN ACT concerning regulation. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 5. The Illinois Insurance Code is amended by 5changing Section 370c.1 as follows: 6    (215 ILCS 5/370c.1)7    Sec. 370c.1. Mental, emotional, nervous, or substance use 8disorder or condition parity.9    (a) On and after July 23, 2021 (the effective date of 10Public Act 102-135), every insurer that amends, delivers, 11issues, or renews a group or individual policy of accident and 12health insurance or a qualified health plan offered through 13the Health Insurance Marketplace in this State providing 14coverage for hospital or medical treatment and for the 15treatment of mental, emotional, nervous, or substance use 16disorders or conditions shall ensure prior to policy issuance 17that:18        (1) the financial requirements applicable to such 19    mental, emotional, nervous, or substance use disorder or 20    condition benefits are no more restrictive than the 21    predominant financial requirements applied to 22    substantially all hospital and medical benefits covered by 23    the policy and that there are no separate cost-sharing   SB1327- 2 -LRB104 10928 BAB 21010 b1    requirements that are applicable only with respect to 2    mental, emotional, nervous, or substance use disorder or 3    condition benefits; and4        (2) the treatment limitations applicable to such 5    mental, emotional, nervous, or substance use disorder or 6    condition benefits are no more restrictive than the 7    predominant treatment limitations applied to substantially 8    all hospital and medical benefits covered by the policy 9    and that there are no separate treatment limitations that 10    are applicable only with respect to mental, emotional, 11    nervous, or substance use disorder or condition benefits.12    (a-5) On and after the effective date of this amendatory 13Act of the 104th General Assembly, every insurer that amends, 14delivers, issues, or renews a group or individual policy or 15certificate of disability insurance or disability income 16insurance in or to any person in this State shall ensure that: 17        (1) the benefits applicable to such mental, emotional, 18    nervous, or substance use disorders or conditions are no 19    more restrictive than the benefits available for all other 20    medical conditions covered by the policy or certificate 21    and that there are no separate requirements that are 22    applicable only with respect to mental, emotional, 23    nervous, or substance use disorder or condition benefits; 24    and 25        (2) the treatment limitations or other coverage 26    limitations applicable to such mental, emotional, nervous,   SB1327- 3 -LRB104 10928 BAB 21010 b1    or substance use disorder or condition benefits are no 2    more restrictive than the benefits available for other 3    physical conditions covered by the policy and that there 4    are no separate payment limitations that may be applied 5    specifically with respect to mental, emotional, nervous, 6    or substance use disorder or condition benefits. 7    (b) The following provisions shall apply concerning 8aggregate lifetime limits:9        (1) In the case of a group or individual policy of 10    accident and health insurance or a qualified health plan 11    offered through the Health Insurance Marketplace amended, 12    delivered, issued, or renewed in this State on or after 13    September 9, 2015 (the effective date of Public Act 14    99-480) that provides coverage for hospital or medical 15    treatment and for the treatment of mental, emotional, 16    nervous, or substance use disorders or conditions the 17    following provisions shall apply:18            (A) if the policy does not include an aggregate 19        lifetime limit on substantially all hospital and 20        medical benefits, then the policy may not impose any 21        aggregate lifetime limit on mental, emotional, 22        nervous, or substance use disorder or condition 23        benefits; or24            (B) if the policy includes an aggregate lifetime 25        limit on substantially all hospital and medical 26        benefits (in this subsection referred to as the   SB1327- 4 -LRB104 10928 BAB 21010 b1        "applicable lifetime limit"), then the policy shall 2        either:3                (i) apply the applicable lifetime limit both 4            to the hospital and medical benefits to which it 5            otherwise would apply and to mental, emotional, 6            nervous, or substance use disorder or condition 7            benefits and not distinguish in the application of 8            the limit between the hospital and medical 9            benefits and mental, emotional, nervous, or 10            substance use disorder or condition benefits; or11                (ii) not include any aggregate lifetime limit 12            on mental, emotional, nervous, or substance use 13            disorder or condition benefits that is less than 14            the applicable lifetime limit.15        (2) In the case of a policy that is not described in 16    paragraph (1) of subsection (b) of this Section and that 17    includes no or different aggregate lifetime limits on 18    different categories of hospital and medical benefits, the 19    Director shall establish rules under which subparagraph 20    (B) of paragraph (1) of subsection (b) of this Section is 21    applied to such policy with respect to mental, emotional, 22    nervous, or substance use disorder or condition benefits 23    by substituting for the applicable lifetime limit an 24    average aggregate lifetime limit that is computed taking 25    into account the weighted average of the aggregate 26    lifetime limits applicable to such categories.   SB1327- 5 -LRB104 10928 BAB 21010 b1    (c) The following provisions shall apply concerning annual 2limits:3        (1) In the case of a group or individual policy of 4    accident and health insurance or a qualified health plan 5    offered through the Health Insurance Marketplace amended, 6    delivered, issued, or renewed in this State on or after 7    September 9, 2015 (the effective date of Public Act 8    99-480) that provides coverage for hospital or medical 9    treatment and for the treatment of mental, emotional, 10    nervous, or substance use disorders or conditions the 11    following provisions shall apply: 12            (A) if the policy does not include an annual limit 13        on substantially all hospital and medical benefits, 14        then the policy may not impose any annual limits on 15        mental, emotional, nervous, or substance use disorder 16        or condition benefits; or17            (B) if the policy includes an annual limit on 18        substantially all hospital and medical benefits (in 19        this subsection referred to as the "applicable annual 20        limit"), then the policy shall either: 21                (i) apply the applicable annual limit both to 22            the hospital and medical benefits to which it 23            otherwise would apply and to mental, emotional, 24            nervous, or substance use disorder or condition 25            benefits and not distinguish in the application of 26            the limit between the hospital and medical   SB1327- 6 -LRB104 10928 BAB 21010 b1            benefits and mental, emotional, nervous, or 2            substance use disorder or condition benefits; or3                (ii) not include any annual limit on mental, 4            emotional, nervous, or substance use disorder or 5            condition benefits that is less than the 6            applicable annual limit. 7        (2) In the case of a policy that is not described in 8    paragraph (1) of subsection (c) of this Section and that 9    includes no or different annual limits on different 10    categories of hospital and medical benefits, the Director 11    shall establish rules under which subparagraph (B) of 12    paragraph (1) of subsection (c) of this Section is applied 13    to such policy with respect to mental, emotional, nervous, 14    or substance use disorder or condition benefits by 15    substituting for the applicable annual limit an average 16    annual limit that is computed taking into account the 17    weighted average of the annual limits applicable to such 18    categories. 19    (d) With respect to mental, emotional, nervous, or 20substance use disorders or conditions, an insurer shall use 21policies and procedures for the election and placement of 22mental, emotional, nervous, or substance use disorder or 23condition treatment drugs on their formulary that are no less 24favorable to the insured as those policies and procedures the 25insurer uses for the selection and placement of drugs for 26medical or surgical conditions and shall follow the expedited   SB1327- 7 -LRB104 10928 BAB 21010 b1coverage determination requirements for substance abuse 2treatment drugs set forth in Section 45.2 of the Managed Care 3Reform and Patient Rights Act. 4    (e) This Section shall be interpreted in a manner 5consistent with all applicable federal parity regulations 6including, but not limited to, the Paul Wellstone and Pete 7Domenici Mental Health Parity and Addiction Equity Act of 82008, final regulations issued under the Paul Wellstone and 9Pete Domenici Mental Health Parity and Addiction Equity Act of 102008 and final regulations applying the Paul Wellstone and 11Pete Domenici Mental Health Parity and Addiction Equity Act of 122008 to Medicaid managed care organizations, the Children's 13Health Insurance Program, and alternative benefit plans.14    (f) The provisions of subsections (b) and (c) of this 15Section shall not be interpreted to allow the use of lifetime 16or annual limits otherwise prohibited by State or federal law.17    (g) As used in this Section:18    "Financial requirement" includes deductibles, copayments, 19coinsurance, and out-of-pocket maximums, but does not include 20an aggregate lifetime limit or an annual limit subject to 21subsections (b) and (c).22    "Mental, emotional, nervous, or substance use disorder or 23condition" means a condition or disorder that involves a 24mental health condition or substance use disorder that falls 25under any of the diagnostic categories listed in the mental 26and behavioral disorders chapter of the current edition of the   SB1327- 8 -LRB104 10928 BAB 21010 b1International Classification of Disease or that is listed in 2the most recent version of the Diagnostic and Statistical 3Manual of Mental Disorders. 4    "Treatment limitation" includes limits on benefits based 5on the frequency of treatment, number of visits, days of 6coverage, days in a waiting period, or other similar limits on 7the scope or duration of treatment, and shall also include 8benefit payments under disability insurance or disability 9income insurance policies or certificates. "Treatment 10limitation" includes both quantitative treatment limitations, 11which are expressed numerically (such as 50 outpatient visits 12per year), and nonquantitative treatment limitations, which 13otherwise limit the scope or duration of treatment, or the 14duration of benefit payments under the terms of a disability 15insurance policy or certificate or disability income insurance 16policy or certificate. A permanent exclusion of all benefits 17for a particular condition or disorder shall not be considered 18a treatment limitation. "Nonquantitative treatment" means 19those limitations as described under federal regulations (26 20CFR 54.9812-1). "Nonquantitative treatment limitations" 21include, but are not limited to, those limitations described 22under federal regulations 26 CFR 54.9812-1, 29 CFR 2590.712, 23and 45 CFR 146.136. 24    (h) The Department of Insurance shall implement the 25following education initiatives:26        (1) By January 1, 2016, the Department shall develop a   SB1327- 9 -LRB104 10928 BAB 21010 b1    plan for a Consumer Education Campaign on parity. The 2    Consumer Education Campaign shall focus its efforts 3    throughout the State and include trainings in the 4    northern, southern, and central regions of the State, as 5    defined by the Department, as well as each of the 5 managed 6    care regions of the State as identified by the Department 7    of Healthcare and Family Services. Under this Consumer 8    Education Campaign, the Department shall: (1) by January 9    1, 2017, provide at least one live training in each region 10    on parity for consumers and providers and one webinar 11    training to be posted on the Department website and (2) 12    establish a consumer hotline to assist consumers in 13    navigating the parity process by March 1, 2017. By January 14    1, 2018 the Department shall issue a report to the General 15    Assembly on the success of the Consumer Education 16    Campaign, which shall indicate whether additional training 17    is necessary or would be recommended.18        (2) The Department, in coordination with the 19    Department of Human Services and the Department of 20    Healthcare and Family Services, shall convene a working 21    group of health care insurance carriers, mental health 22    advocacy groups, substance abuse patient advocacy groups, 23    and mental health physician groups for the purpose of 24    discussing issues related to the treatment and coverage of 25    mental, emotional, nervous, or substance use disorders or 26    conditions and compliance with parity obligations under   SB1327- 10 -LRB104 10928 BAB 21010 b1    State and federal law. Compliance shall be measured, 2    tracked, and shared during the meetings of the working 3    group. The working group shall meet once before January 1, 4    2016 and shall meet semiannually thereafter. The 5    Department shall issue an annual report to the General 6    Assembly that includes a list of the health care insurance 7    carriers, mental health advocacy groups, substance abuse 8    patient advocacy groups, and mental health physician 9    groups that participated in the working group meetings, 10    details on the issues and topics covered, and any 11    legislative recommendations developed by the working 12    group.13        (3) Not later than January 1 of each year, the 14    Department, in conjunction with the Department of 15    Healthcare and Family Services, shall issue a joint report 16    to the General Assembly and provide an educational 17    presentation to the General Assembly. The report and 18    presentation shall: 19            (A) Cover the methodology the Departments use to 20        check for compliance with the federal Paul Wellstone 21        and Pete Domenici Mental Health Parity and Addiction 22        Equity Act of 2008, 42 U.S.C. 18031(j), and any 23        federal regulations or guidance relating to the 24        compliance and oversight of the federal Paul Wellstone 25        and Pete Domenici Mental Health Parity and Addiction 26        Equity Act of 2008 and 42 U.S.C. 18031(j).  SB1327- 11 -LRB104 10928 BAB 21010 b1            (B) Cover the methodology the Departments use to 2        check for compliance with this Section and Sections 3        356z.23 and 370c of this Code.4            (C) Identify market conduct examinations or, in 5        the case of the Department of Healthcare and Family 6        Services, audits conducted or completed during the 7        preceding 12-month period regarding compliance with 8        parity in mental, emotional, nervous, and substance 9        use disorder or condition benefits under State and 10        federal laws and summarize the results of such market 11        conduct examinations and audits. This shall include: 12                (i) the number of market conduct examinations 13            and audits initiated and completed;14                (ii) the benefit classifications examined by 15            each market conduct examination and audit;16                (iii) the subject matter of each market 17            conduct examination and audit, including 18            quantitative and nonquantitative treatment 19            limitations; and20                (iv) a summary of the basis for the final 21            decision rendered in each market conduct 22            examination and audit.23            Individually identifiable information shall be 24        excluded from the reports consistent with federal 25        privacy protections.26            (D) Detail any educational or corrective actions   SB1327- 12 -LRB104 10928 BAB 21010 b1        the Departments have taken to ensure compliance with 2        the federal Paul Wellstone and Pete Domenici Mental 3        Health Parity and Addiction Equity Act of 2008, 42 4        U.S.C. 18031(j), this Section, and Sections 356z.23 5        and 370c of this Code.6            (E) The report must be written in non-technical, 7        readily understandable language and shall be made 8        available to the public by, among such other means as 9        the Departments find appropriate, posting the report 10        on the Departments' websites. 11    (i) The Parity Advancement Fund is created as a special 12fund in the State treasury. Moneys from fines and penalties 13collected from insurers for violations of this Section shall 14be deposited into the Fund. Moneys deposited into the Fund for 15appropriation by the General Assembly to the Department shall 16be used for the purpose of providing financial support of the 17Consumer Education Campaign, parity compliance advocacy, and 18other initiatives that support parity implementation and 19enforcement on behalf of consumers. 20    (j) (Blank). 21    (j-5) The Department of Insurance shall collect the 22following information:23        (1) The number of employment disability insurance 24    plans offered in this State, including, but not limited 25    to:26            (A) individual short-term policies;  SB1327- 13 -LRB104 10928 BAB 21010 b1            (B) individual long-term policies;2            (C) group short-term policies; and3            (D) group long-term policies.4        (2) The number of policies referenced in paragraph (1) 5    of this subsection that limit mental health and substance 6    use disorder benefits.7        (3) The average defined benefit period for the 8    policies referenced in paragraph (1) of this subsection, 9    both for those policies that limit and those policies that 10    have no limitation on mental health and substance use 11    disorder benefits.12        (4) Whether the policies referenced in paragraph (1) 13    of this subsection are purchased on a voluntary or 14    non-voluntary basis.15        (5) The identities of the individuals, entities, or a 16    combination of the 2 that assume the cost associated with 17    covering the policies referenced in paragraph (1) of this 18    subsection.19        (6) The average defined benefit period for plans that 20    cover physical disability and mental health and substance 21    abuse without limitation, including, but not limited to:22            (A) individual short-term policies;23            (B) individual long-term policies;24            (C) group short-term policies; and25            (D) group long-term policies.26        (7) The average premiums for disability income   SB1327- 14 -LRB104 10928 BAB 21010 b1    insurance issued in this State for:2            (A) individual short-term policies that limit 3        mental health and substance use disorder benefits;4            (B) individual long-term policies that limit 5        mental health and substance use disorder benefits;6            (C) group short-term policies that limit mental 7        health and substance use disorder benefits;8            (D) group long-term policies that limit mental 9        health and substance use disorder benefits;10            (E) individual short-term policies that include 11        mental health and substance use disorder benefits 12        without limitation;13            (F) individual long-term policies that include 14        mental health and substance use disorder benefits 15        without limitation;16            (G) group short-term policies that include mental 17        health and substance use disorder benefits without 18        limitation; and19            (H) group long-term policies that include mental 20        health and substance use disorder benefits without 21        limitation.22    The Department shall present its findings regarding 23information collected under this subsection (j-5) to the 24General Assembly no later than April 30, 2024. Information 25regarding a specific insurance provider's contributions to the 26Department's report shall be exempt from disclosure under   SB1327- 15 -LRB104 10928 BAB 21010 b1paragraph (t) of subsection (1) of Section 7 of the Freedom of 2Information Act. The aggregated information gathered by the 3Department shall not be exempt from disclosure under paragraph 4(t) of subsection (1) of Section 7 of the Freedom of 5Information Act.6    (k) An insurer that amends, delivers, issues, or renews a 7group or individual policy of accident and health insurance or 8a qualified health plan offered through the health insurance 9marketplace in this State providing coverage for hospital or 10medical treatment and for the treatment of mental, emotional, 11nervous, or substance use disorders or conditions shall submit 12an annual report, the format and definitions for which will be 13determined by the Department and the Department of Healthcare 14and Family Services and posted on their respective websites, 15starting on September 1, 2023 and annually thereafter, that 16contains the following information separately for inpatient 17in-network benefits, inpatient out-of-network benefits, 18outpatient in-network benefits, outpatient out-of-network 19benefits, emergency care benefits, and prescription drug 20benefits in the case of accident and health insurance or 21qualified health plans, or inpatient, outpatient, emergency 22care, and prescription drug benefits in the case of medical 23assistance: 24        (1) A summary of the plan's pharmacy management 25    processes for mental, emotional, nervous, or substance use 26    disorder or condition benefits compared to those for other   SB1327- 16 -LRB104 10928 BAB 21010 b1    medical benefits.2        (2) A summary of the internal processes of review for 3    experimental benefits and unproven technology for mental, 4    emotional, nervous, or substance use disorder or condition 5    benefits and those for other medical benefits.6        (3) A summary of how the plan's policies and 7    procedures for utilization management for mental, 8    emotional, nervous, or substance use disorder or condition 9    benefits compare to those for other medical benefits.10        (4) A description of the process used to develop or 11    select the medical necessity criteria for mental, 12    emotional, nervous, or substance use disorder or condition 13    benefits and the process used to develop or select the 14    medical necessity criteria for medical and surgical 15    benefits. 16        (5) Identification of all nonquantitative treatment 17    limitations that are applied to both mental, emotional, 18    nervous, or substance use disorder or condition benefits 19    and medical and surgical benefits within each 20    classification of benefits.21        (6) The results of an analysis that demonstrates that 22    for the medical necessity criteria described in 23    subparagraph (A) and for each nonquantitative treatment 24    limitation identified in subparagraph (B), as written and 25    in operation, the processes, strategies, evidentiary 26    standards, or other factors used in applying the medical   SB1327- 17 -LRB104 10928 BAB 21010 b1    necessity criteria and each nonquantitative treatment 2    limitation to mental, emotional, nervous, or substance use 3    disorder or condition benefits within each classification 4    of benefits are comparable to, and are applied no more 5    stringently than, the processes, strategies, evidentiary 6    standards, or other factors used in applying the medical 7    necessity criteria and each nonquantitative treatment 8    limitation to medical and surgical benefits within the 9    corresponding classification of benefits; at a minimum, 10    the results of the analysis shall:11            (A) identify the factors used to determine that a 12        nonquantitative treatment limitation applies to a 13        benefit, including factors that were considered but 14        rejected;15            (B) identify and define the specific evidentiary 16        standards used to define the factors and any other 17        evidence relied upon in designing each nonquantitative 18        treatment limitation;19            (C) provide the comparative analyses, including 20        the results of the analyses, performed to determine 21        that the processes and strategies used to design each 22        nonquantitative treatment limitation, as written, for 23        mental, emotional, nervous, or substance use disorder 24        or condition benefits are comparable to, and are 25        applied no more stringently than, the processes and 26        strategies used to design each nonquantitative   SB1327- 18 -LRB104 10928 BAB 21010 b1        treatment limitation, as written, for medical and 2        surgical benefits;3            (D) provide the comparative analyses, including 4        the results of the analyses, performed to determine 5        that the processes and strategies used to apply each 6        nonquantitative treatment limitation, in operation, 7        for mental, emotional, nervous, or substance use 8        disorder or condition benefits are comparable to, and 9        applied no more stringently than, the processes or 10        strategies used to apply each nonquantitative 11        treatment limitation, in operation, for medical and 12        surgical benefits; and13            (E) disclose the specific findings and conclusions 14        reached by the insurer that the results of the 15        analyses described in subparagraphs (C) and (D) 16        indicate that the insurer is in compliance with this 17        Section and the Mental Health Parity and Addiction 18        Equity Act of 2008 and its implementing regulations, 19        which includes 42 CFR Parts 438, 440, and 457 and 45 20        CFR 146.136 and any other related federal regulations 21        found in the Code of Federal Regulations.22        (7) Any other information necessary to clarify data 23    provided in accordance with this Section requested by the 24    Director, including information that may be proprietary or 25    have commercial value, under the requirements of Section 26    30 of the Viatical Settlements Act of 2009.  SB1327- 19 -LRB104 10928 BAB 21010 b1    (l) An insurer that amends, delivers, issues, or renews a 2group or individual policy of accident and health insurance or 3a qualified health plan offered through the health insurance 4marketplace in this State providing coverage for hospital or 5medical treatment and for the treatment of mental, emotional, 6nervous, or substance use disorders or conditions on or after 7January 1, 2019 (the effective date of Public Act 100-1024) 8shall, in advance of the plan year, make available to the 9Department or, with respect to medical assistance, the 10Department of Healthcare and Family Services and to all plan 11participants and beneficiaries the information required in 12subparagraphs (C) through (E) of paragraph (6) of subsection 13(k). For plan participants and medical assistance 14beneficiaries, the information required in subparagraphs (C) 15through (E) of paragraph (6) of subsection (k) shall be made 16available on a publicly available website whose web address is 17prominently displayed in plan and managed care organization 18informational and marketing materials.19    (m) In conjunction with its compliance examination program 20conducted in accordance with the Illinois State Auditing Act, 21the Auditor General shall undertake a review of compliance by 22the Department and the Department of Healthcare and Family 23Services with Section 370c and this Section. Any findings 24resulting from the review conducted under this Section shall 25be included in the applicable State agency's compliance 26examination report. Each compliance examination report shall   SB1327- 20 -LRB104 10928 BAB 21010 b1be issued in accordance with Section 3-14 of the Illinois 2State Auditing Act. A copy of each report shall also be 3delivered to the head of the applicable State agency and 4posted on the Auditor General's website. 5(Source: P.A. 102-135, eff. 7-23-21; 102-579, eff. 8-25-21; 6102-813, eff. 5-13-22; 103-94, eff. 1-1-24; 103-105, eff. 76-27-23; 103-605, eff. 7-1-24.)